Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Investment of the day
    • NirogStreet raises Rs...

    NirogStreet raises Rs 2 crore from Spiral Ventures

    Written by Ruby Khatun Khatun Published On 2018-06-14T10:00:55+05:30  |  Updated On 14 Jun 2018 10:00 AM IST
    NirogStreet raises Rs 2 crore from Spiral Ventures

    New Delhi: India's first technology-led Ayurveda platform, NirogStreet on Wednesday announced raising USD 300k (Rs 2 crore) from the Japanese venture fund Spiral Ventures, Subho Ray (President, IAMAI) and Samir Kumar (Director of Derivatives at Deutsche Bank, Singapore).


    With the maximum focus on technological advancements, NirogStreet will work towards building back the trust and preference for Ayurveda treatment and practitioners across the world by encouraging evidence-based practices.


    The funds will be utilized in spreading awareness and visibility about Ayurveda as the people are not appropriately aware of the benefits the ayurvedic treatment embodies and its rich medical knowledge.


    "We are happy that we have found partners who have the same trust in Ayurveda as we have and are supporting the growth of our endeavors," said Ram N Kumar, founder, and CEO, NirogStreet.


    "NirogStreet is a platform where doctors can interact with each other, share knowledge and buy high-quality medicines. In Ayurveda ecosystem, Ayurveda doctors, apart from consultation, also dispense medicines. We are working to provide high-quality medicine at right margin to the doctors at the doorstep. Our constant is trying to create a win-win scenario for every Ayurveda doctor as we help advance this great medical system at a global scale," he added.


    "We look forward to a constructive development in this field. NirogStreet can play an important role for all stakeholders of the Ayurveda industry as well as healthcare," said spokesperson from the Japanese venture fund Spiral Ventures.


    Adding to this, Subho Ray, President of IAMAI said that reviving the trust and accessibility of Ayurveda can bring multifold benefits and advantages for the community as well as people and open new opportunities and avenues in the Medicare world.


    "What NirogStreet aims to accomplish will benefit both the people and the practitioners. Ayurveda is the future," added Director of Derivatives at Deutsche Bank, Singapore, Samir Kumar.


    So far, NirogStreet is the most recognizable online brand in Ayurveda with over 15,000 doctors engaged on its platform so far.


    However, the company aims to raise pre-series A funding in October 2018.

    Ayurveda doctorsAyurveda platformAyurveda treatmentdoctorsfundfundingJapanese venture fundmedical knowledgeNirogStreetRaisesRam N KumarSamir KumarSpiral VenturesSubho Ray
    Source : ANI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok